Search results

  1. Rheumatoid arthritis

    Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart

  2. Chronic heart failure

    Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart

  3. Non-Hodgkin's lymphoma

    Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart

  4. Ear, nose and throat conditions

    Everything NICE has said on ear, nose and throat conditions in an interactive flowchart

  5. Faecal incontinence

    Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart

  6. In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March (excluding those with pre-existing CHD, stroke and/or TIA), who have a recorded CVD risk assessment score (using the QRISK2 assessment tool) of more than 20% in the preceding 12 months: the percentage who are currently treated with statins (unless there is a contraindication)

    In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March...

  7. Bladder cancer

    Everything NICE has said on bladder cancer in adults in an interactive flowchart

  8. Atrial fibrillation

    Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart

  9. Ovarian cancer

    Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart

  10. Preterm labour and birth

    Everything NICE has said on the care of women in or at risk of preterm labour or having a planned preterm birth in an interactive flowchart

  11. Sarcoma

    Everything NICE has said on sarcoma in an interactive flowchart

  12. Stroke

    Everything NICE has said on preventing, diagnosing and managing stroke and transient ischaemic attack (TIA) in people over 16 in an interactive flowchart

  13. Neuropathic pain

    Everything NICE has said on pharmacological management of neuropathic pain in adults in non-specialist settings in an interactive flowchart

  14. Lower limb peripheral arterial disease

    Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart

  15. Low back pain and sciatica

    Everything NICE has said on low back pain and sciatica in an interactive flowchart

  16. Physical activity

    Everything NICE has said on interventions, programmes and strategies to encourage people of all ages to be physically active in an interactive flowchart

  17. Obesity

    Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart

  18. Age-related macular degeneration

    Everything NICE has said on age-related macular degeneration in an interactive flowchart

  19. Asthma

    Everything NICE has said on diagnosing, monitoring and managing asthma in children, young people and adults in an interactive flowchart

  20. Caesarean section

    Everything NICE has said on caesarean section in an interactive flowchart

  21. Suspected cancer recognition and referral

    Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart

  22. Brain tumours and metastases

    Everything NICE has said on brain tumours in adults, including cancer, in an interactive flowchart

  23. Cervical cancer

    Everything NICE has said on screening and managing cervical cancer in an interactive flowchart

  24. Lung cancer

    Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart

  25. Oesophageal and gastric cancer

    Everything NICE has said on assessing and managing non-stromal oesophageal and gastric cancer in adults

  26. Skin conditions

    Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart

  27. Abortion care (QS199)

    This quality standard covers care for women of any age (including girls and young women under 18) who request an abortion. It describes high-quality care in priority areas for improvement.

  28. Abortion care

    Everything NICE has said on abortion care in an interactive flowchart.

  29. Venous thromboembolism in adults: diagnosis and management (QS29)

    This quality standard covers diagnosing and treating venous thromboembolism (VTE) in adults. VTE includes deep vein thrombosis (DVT) and pulmonary embolism. It describes high-quality care in priority areas for improvement.

  30. What are the most clinically effective interventions (including social prescribing and structured community support) for managing post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Do any symptoms of post‑COVID‑19 syndrome predict the need for specialist intervention? Are there clusters of symptoms that identify response to interventions in post‑COVID‑19 syndrome? What is the clinical effectiveness of different service models of multimodality/multidisciplinary post‑COVID‑19 syndrome rehabilitation in improving patient‑reported outcomes (such as quality of life)? What is the clinical effectiveness of exercise interventions for people with post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Does early exercise rehabilitation assist in improving symptoms of post‑COVID‑19 syndrome?

    Recommendation ID NG188/2 Question What are the most clinically effective interventions (including social prescribing and structured community

  31. Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data.   Find out  what only in research means on the NICE interventional procedures guidance page .

    Recommendation ID IPG683/1 Question Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus

  32. Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data.   Find out  what only in research means on the NICE interventional procedures guidance page .

    Recommendation ID IPG682/1 Question Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate

  33. Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent but potentially serious adverse events: For people who need to lose weight in the short term for medical reasons, the evidence of efficacy is adequate to support the use of this procedure provided that special arrangements are in place for clinical governance, consent and audit.  Find out  what special arrangements mean on the NICE interventional procedures guidance page . For people who are aiming for long-term weight loss, the evidence on efficacy is inadequate in quantity and quality, so the procedure should only be used in the context of research.   Find out  what only in research means on the NICE interventional procedures guidance page .

    Recommendation ID IPG684/1 Question Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent